Thầy thuốc tận tâmChăm mầm đất nướcMOH, 2016... Thầy thuốc tận tâmChăm mầm đất nước... Thầy thuốc tận tâmChăm mầm đất nướcImmunopathogenesis of Dengue Simmons CP et al.2012... Thầy thuốc
Trang 1Thầy thuốc tận tâm
Trang 2Ba điều làm tôi hạnh phúchôm nay!
Trang 4Thầy thuốc tận tâmChăm mầm đất nước
(MOH, 2016)
Trang 5Thầy thuốc tận tâmChăm mầm đất nước
Trang 6Thầy thuốc tận tâmChăm mầm đất nước
Immunopathogenesis of Dengue (Simmons CP et al.(2012) N Engl J
Med 366;15, 1423-1432)
Trang 7Thầy thuốc tận tâm
Dengue virus infection
The correlation between pathophysiologyand clinical manifestations of DHF
(Hung and Thanh, 2002)
Trang 8Thầy thuốc tận tâmChăm mầm đất nước
(PAHO, Dengue- Guidelines for patient care in the Region of the Americas, 2016)
Trang 9Thầy thuốc tận tâm
Chăm mầm đất nước Phân độ nặng Lâm sàng SXHD
Trang 10Thầy thuốc tận tâmChăm mầm đất nước
Phânbố theo tuổi bệnh nhân SXHD, Việt Nam
(CT SXHQG, 2017)
10
Trang 11Thầy thuốc tận tâm
Trang 16* Some studies on infants
* Most cases -Secondary infections
* Many studies on the clinical, epidemiological, and immunological aspects.
Understand the immunopathogenesis of Dengue
Study Dengue in infants
Trang 17LÂM SÀNG SXHNN
As in older children and adults, dengue virus can cause a spectrum of outcomes in infants, ranging from asymptomatic infection to mild or clinically
significant, severe disease
(*WHO, Handbook for clinical management of Dengue, 2012; **PAHO, Dengue- Guidelines for patient care in the Region of the Americas, 2016)
Trang 18Thầy thuốc tận tâm
Chăm mầm đất nước Clinical manifestations
(WHO, 2012; PAHO, 2016)
High fever, 2–7 days
URT symptoms (cough, nasal congestion, runny nose, dyspnea),
GI symptoms (vomiting, diarrhea).Febrile convulsions
Trang 19Thầy thuốc tận tâm
Trang 20Thầy thuốc tận tâmChăm mầm đất nước
Increase in Hct ≥ 20%
The normal value of Hct in infants 2–12 months of
age is relatively low (28–42%) and may be even lower in iron deficiency anemia The mean maximal Hct
values in dengue infants vary from 31.1−40.8%
Trang 21TDMP / SXH IV, trẻ 11 tháng.
(Hung et al., 2004)
Trang 22DHF IN INFANTS
95.3% had primary dengue infectionsAge: 6.7 2.5 months (1-11 months)
Trang 24Đặc điểm xét nghiệm
Tất cả BN SXH không sốc Sốc SXH
Trang 26Đáp ứng miễn dịch trong SXH Dengue NN
Capture IgM và IgG ELISA
Đáp ứng MD Tất cả BNSXH không sốc Sốc SXH P
Trang 27Ngày bệnh N3 N4 N5 N6 N7 N8 Tcộng
Sốc ca, 6 45 92 71 30 1 245
% (2,4) (18,3) (37,5) (28,9) (12,2) (0,4) (100)
Phân bố kết quả IgM (+) theo ngày bệnh
79,3% trẻ NN có KT IgM (+) từ ngày thứ 5 trở đi và đáp ứng chéo rất ít với vi rút VN Nhật Bản > Thử
IgM ELISA từ N5 trở đi giúp + các trường hợp SXHNN.
Trang 28Đáp ứng MD của các bà mẹ đ/v vi rút Dengue98 trong 99 (98,8%) bà mẹ có đáp ứng HT (+) qua NS1 serotype- specific IgG ELISA:
* 87,8% bà mẹ đã bị nhiễm Dengue 2 lần (đáp ứng kiểu tái nhiễm);
* 12,2 % bị nhiễm 1 lần (đáp ứng kiểu sơ nhiễm)
Trang 29The sensitivity of diagnostic tests in acute DENV infection of infants
(Chau et al PLoS Negl Trop Dis 2010 Apr 13;4(4):e657)
Trang 30Cytokine Profile in Infants with DHF/DSS.
Using BD Human Th1/Th2
Cytokine Cytometric BeadArray Kit-II & Flow Cytometry
to determine the plasma levels of
Trang 31Overproduction of both proinflammatory cytokines (IFN-γ and TNF-α) and anti-inflammatory cytokines (IL-10 and IL-6) may play a role in the pathogenesis of DHF/DSS in infants.
[Hung et al (2004) J of Infectious Diseases, 189:221-232]
Trang 32Vai trò KT IgG của mẹ truyền qua con qua nhau thai trong sinh bệnh học SXH NN
Mối liên hệ giữa phân phối tuổi trẻ nhũ nhi bị SXH/ SốcSXH và hiệu quả bảo vệ và thúc đẩy nhiễm trùng của
kháng thể từ mẹ (Halstead, Lan et al Emerging Inf Dis,
Dec,2002, 1474-1479) ).
Trang 33* Severe dengue is less common in infancy but when it does occur the risk of dying is higher than in older children and adults
* Infants with dengue should be referred for in-hospital management (WHO, 2012).
ĐIỀU TRỊ SXHNN
Trang 35208 trường hợp nhũ nhi
Trang 36Đặc điểm điều trị SXH NN Tất cả BNSXH không sốcSốc SXH
(n=208)(n=145) (n=63) Lượng dịch TTM110,4 33,6102,1 28,4 P<0,001 129,8 36,9
Tỉ lệ dùng CPT48 (23%) 13 (8,9%) P<0,001 35 (55,5%)
Lượng CPT55,1 25,939,4 16,2 P=0,01 60,9 26,5
Tỉ lệ truyền máu28 (13,4%) 11 (7,5%) P<0,001 17 (26,9%)Lượng máu tươi38,7 32,5 27,3 18,2 P=0,1 44,7 38,1Thời gian TTM(giờ) 25,8 8,825,9 8,1 P=0,5 25,7 10,2
[Hung et al 2006, Am J Trop Med Hyg 72: 370- 374]
Trang 38(WHO-SEARO, Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever 2011)
Trang 40Về điều trị sốc SXH NN:
* 55,5% cần truyền CPT, 26,9% cần truyềnmáu>< Trẻ lớn: 22,6- 44,6% cần CPT;
15,6% cần truyền máu [Nimman.1987; Chi
Trang 41*[Hung et al (2006) Am J Trop Med Hyg.,74(4):684-691]
Average amount of fluid in adults with DSS <= 80 ml/ kg/ 24 hrs [Hien TT, 2005]
Trang 42Điều trị biến chứng xuất huyết, hạ Natrimáu, và toan hóa máu chuyển hóa
42
Trang 43Rev Cubana Med Trop.1993;45(2):97-101.[Dengue fever and hemorrhagic dengue in
infants with a primary infection]
Trang 441
Trang 45Am J Trop Med Hyg 74(4), 2006, pp 684-691
2
Trang 47Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT, Lien le B, Quy NT, Hieu NT, Hien TT, McElnea C, Young P, Whitehead S, Hung NT, Farrar J.
J Infect Dis 2007 Aug 1;196(3):416-24 Epub 2007 Jun 19.
birth cohort study of Vietnamese infants.
Chau TN, Hieu NT, Anders KL, Wolbers M, Lien le B, Hieu LT, Hien TT, Hung NT, Farrar J, Whitehead S, Simmons CP.
J Infect Dis 2009 Dec 15;200(12):1893-900
correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity.
Chau TN, Quyen NT, Thuy TT, Tuan NM, Hoang DM, Dung NT, Lien le B, Quy NT, Hieu NT, Hieu LT, Hien TT, Hung NT, Farrar J, Simmons CP.
J Infect Dis 2008 Aug 15;198(4):516-24.
Chau TN, Anders KL, Lien le B, Hung NT, Hieu LT, Tuan NM, Thuy TT, Phuong le T, Tham NT, Lanh MN, Farrar JJ, Whitehead SS, Simmons CP.PLoS Negl Trop Dis 2010 Apr 13;4(4):e657
Trang 48Vertical Transmissionand Neonatal Dengue
Dengue & Pregnancy?
Trang 49The Effects of Dengue on the Pregnancy (WHO, 2012, PAHO, 2016)
- Maternal death from Dengue is infrequently.
- Pregnant women may miscarryor be at risk of miscarriage or prematureduring or up to one month following Dengue infection.
-Fetal growth retardation occurs in a variable proportion of Dengue cases (4-17%) in pregnant women.
49
Trang 50One comparative study that tested 64 umbilical cord serum samples for dengue IgMfrom 63 women who were found to be IgM positive at the time of delivery,
(Tan P et al Obstetrical & Gynecological Survey, 2008, 111:1111–1117.)
Dengue virus can be vertically transmitted to the fetus in utero or to the newborn at parturition
Trang 51Compare events and pregnancy outcomes between two paired groups of pregnant women: women having presented with
symptomatic dengue during pregnancy (n = 73) and women having had neither fever nor dengue during pregnancy (n = 219) 27% of the women with symptomatic dengue had at least one clinical or biological warning sign These
complications occurred after the 28th week of gestation in 55% of cases
(Basurko C, Everhard S, Matheus S, Restrepo M, HildeÂral H, Lambert V, et al (2018) Aprospective matched study on symptomatic
dengue in pregnancy PLoS ONE 13(10): e0202005).
51
Trang 52• Exposure to dengue during pregnancy was not
significantly associated with prematurity, small for gestational age infants, hypertension or
emergency caesarian section.
• Maternal dengue with warning signs was a risk
factor for peripartum hemorrhage with adjusted relative risk = 8.6 (95% CI = 1.2±62) There was a near significant association between dengue
and in utero death (p = 0.09).
(Basurko C, Everhard S, Matheus S, Restrepo M, HildeÂral H,
Lambert V, et al (2018) Aprospective matched study on symptomaticdengue in pregnancy PLoS ONE 13(10): e0202005).
52
Trang 53• Asymptomatic,
hepatomegaly,
bleeding, circulatory failure, massive intracerebralhemorrhage and death
Clinical manifestations of vertically infected neonates
Trang 54* Clinical presentation in the newborn infant does not appear to be associated with maternal disease severity or dengue immune status, or mode of
* Timing of maternal infection may be important; peripartum maternal infection may increase the likelihood of symptomatic disease in the newborn
54
Trang 55A review of 17 mother–infant pairs with dengue infection
onset of fever and that of their neonates, were 5–13 days (median, 7 days)
• Fever in neonates occurred at 1–11 days of life(median, 4 days)
• The duration of fever in neonates was 1–5 days(median, 3 days)
(Sirinavin S et al Pediatric Infectious Disease Journal,2004, 23:1042–1047.)
55
Trang 56Antibodies to the dengue virus in the dengue infected mother can cross the placenta and can cause severe dengue in infants
56
Trang 57Management of neonatal dengue
* When a pregnant or parturient woman develops signs consistent with dengue, the diagnosis of
dengue should be considered in her neonate
* Remember that some neonates have become ill as long as 11 days after birth
57
Trang 58Management of neonatal dengue
* The diagnosis of neonatal dengue could eventually be suspected on clinical grounds and then confirmed in the laboratory, but initial presentation may be confused with bacterial sepsis, birth trauma and other causes of neonatal illness.
* Symptomatic and supportive treatment under close observation is the mainstay of treatment.
58
Trang 59Results: 23 patients were reported
≤ 7 days of life: 18 cases> 7 days of life: 5 cases
• There were 16 mothers have fever, and among them, 10 mothers were diagnosed DHFat or near time of
A Study of Neonatal Dengue at Children’s Hospital 2-Ho Chi Minh City, March 2008- June, 2012
(Nguyen Thi Kim Anh, Tran Thi Hoa Phuong, 2016)
Trang 60The clinical symptoms:
• Others: Jaundice (8 newborns); Poor feeding (5);
Vomiting (4); wheezing (2), cough (10), diarrhea (1)
60
Trang 61• WBC count < 5,000/mm3 : 3 newborns
• Coagulation abnormalities: 5 newborns
• X-ray (n=17): 6 newborns having mild pleural effusion.• Abdominal ultrasound exam (n=17): 6 newborns having
signs of gallbladder wall thickening and intraperitonealfree fluid
61
Trang 62Serology for Dengue of babies:
• IgM(+) and IgG(-): 18 newborns • IgM(+) and IgG(+): 5 newborns.
Serology for Dengue of mothers (17 tested cases):
IgM(+) and IgG(+): 8 mothersIgM(+) and IgG(-): 4 mothers
62
Trang 63The treatment:
* Fluid transfusion: 2 newborns
• Platelet transfusion: 12 newborns
• Frozen fresh plasma transfusion: 4 newborns• Blood transfusion: 1 newborns
Outcome:No death.
63
Trang 64Đặc điểm sốt xuất huyết ở trẻ sơ sinh tại
- 100% bn có tiền sử mẹ được chẩn đoán SXH-D trong giai đoạn chu sinh
- Tuổi bắt đầu sốt là 5 (IQR: 4, 8) ngày sau khi sinh
- Thời gian sốt tổng cộng là 3 (IQR: 2, 4) ngày
Trang 66• Chẩn đoán ban đầu: NTH SS
• SXH-D: 18,8%, SXH-D cảnh báo: 81,2%
• Chỉ có 6,3% trường hợp được truyền dịch nhằm mục
đích duy trì nhu cầu cơ bản và ngưng truyền trước 24 giờ Chỉ có 1 trường hợp được chỉ định truyền TC vì TC giảm nặng <10000/mm3
66
Trang 67Conclusions
It is difficult to diagnose neonatal DHF early and
differentiate with neonatal sepsis We should suspect of neonatal DHF if the neonate has fever lasting for 3-4 days, thrombocytopenia and good general condition, meanwhile, other investigations for bacterial infections being normal, and maternal history with having DHF at or near time of delivery (Nguyen Thi Kim Anh, Tran Thi Hoa Phuong, 2016; Tuan et al., 2017).
67
Trang 68• Prof Nguyen Trong Lan; Dr Bach Van Cam (Vietnam)• Prof Scott Halstead; Prof Duane J Gubler (USA)
• Prof Suchitra Nimmanitya; Dr Siripen
Kalayanarooj (Thailand)
• Prof Huan-Yao Lei; Prof Ching-Chuan Liu; Dr JH
Huang (Taiwan)
• Colleagues at Children’s Hospital 1 &2; Hospital for
Tropical Diseases; Oxford University Clinical Research Unit (OCRU); Pasteur Institutes- Ho Chi Minh City
Trang 69Am J Trop Med Hyg., 00(0), 2018, p 1
doi:10.4269/ajtmh.18-0695Copyright © 2018 by The American Society of Tropical Medicine and Hygiene
Trang 70Thầy thuốc tận tâmKhối 3: khối điều trị
nội trú theo yêu cầu
Trang 71Thầy thuốc tận tâmChăm mầm đất nước